AzTrials
AzTrials

Ventilator-Associated PneumoniaPhase 2/3RASPALLNCT00842478

Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia

A Phase 2/3 study testing Toothbrushing in people with Ventilator-Associated Pneumonia and Nosocomial Pneumonia, run by Hospital Universitari Joan XXIII de Tarragona. at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Poor oral hygiene is associated with respiratory pathogen colonization and secondary lung infection.The possible association between oral care and incidence of VAP, and the role of dental plaque, mouth and tracheal colonization have not been firmly established. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Toothbrushing
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteSpain
Study dates
May 2005to not given
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult intubated patients
  • Without evidence of pulmonary infection (randomized within 12h of intubation if they were expected to remain ventilated for longer than 48 hours)

Who cannot join

  • Absence of dental pieces
  • Current diagnosis of pneumonia or massive bronchoaspiration
  • Tracheostomy (or expected within 48 hours)
  • Chlorhexidine allergy

Trial locations and contacts

1 site in 1 country.

Angel Pobo, MD contact

34 977 295818

angel.pobo@gmail.com

Spain1 site, 1 recruiting
  • ICU, Hospital Universitari Joan XXIII

    Tarragona, Tarragona, 43005

    Angel Pobo, MD, 34 977295818, angel.pobo@gmail.com

    Angel Pobo, MD

    Recruiting

Other trials in Spain

About this study

Poor oral hygiene is associated with respiratory pathogen colonization and secondary lung infection.The possible association between oral care and incidence of VAP, and the role of dental plaque, mouth and tracheal colonization have not been firmly established. The investigators' hypothesis was that improving oral care with electrical toothbrushing might be effective in reducing the incidence of VAP.

Being tested
Toothbrushing
Medical subject headings
Pneumonia, Ventilator-Associated, Healthcare-Associated Pneumonia, Pneumonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ToothbrushingProcedure or surgery

Study groups in NCT00842478
Study groupRoleWhat they receive
RaspallExperimentalNot described
Receives: Procedure: Toothbrushing
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ventilator-Associated Pneumonia (VAP)

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2009 (estimated)
  2. Study startMay 2005

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00842478
Sponsor's protocol ID
FIS 06/0060
Acronym
RASPALL
Status last verified
Feb 2009
First submitted
11 Feb 2009
Last updated
12 Feb 2009
Results posted
No
Data monitoring committee
Yes

Publications

  • Pobo A, Lisboa T, Rodriguez A, Sole R, Magret M, Trefler S, Gomez F, Rello J; RASPALL Study Investigators. A randomized trial of dental brushing for preventing ventilator-associated pneumonia. Chest. 2009 Aug;136(2):433-439. doi: 10.1378/chest.09-0706. Epub 2009 May 29.

    PubMed 19482956

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Toothbrushing in people with Ventilator-Associated Pneumonia and Nosocomial Pneumonia, run by Hospital Universitari Joan XXIII de Tarragona. at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Feb 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Angel Pobo, MD (34 977 295818, angel.pobo@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ventilator-Associated Pneumonia (VAP) (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00842478, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in